Recombinant IL-7: Interim Phase I/IIa data

Interim data from 16 treatment-experienced patients with chronic HCV genotype 1 or 4 infection in the open-label, dose-escalation, European Phase I/IIa ECLIPSE 2 trial showed that once-weekly subcutan...